Novartis Ireland Marks Collaboration Agreement With Deciphex
recent articles
Xtalks: Featured speaker from Proscia will share real-world examples and use cases during free event. TORONTO, ONTARIO, CANADA (PRWEB) MAY 01, 2023 Preclinical research and development (R&D) centers around workflows that generate more...
Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding...
Exeter, England, April 19th 2023 — Diagnexia UK Limited, owned by Deciphex, is the UK's fastest-growing pathology diagnostics service provider. Today, the company proudly celebrated the launch of its expanded facility at Exeter Science Park....
PathAI and ConcertAI: Researchers derive novel insights through the combination of PathAI's proprietary tumor microenvironment features with ConcertAI's multi-modal clinical data BOSTON, April 25, 2023 /PRNewswire/ -- PathAI, a global...
Indica Labs and Lunit: Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution. ALBUQUERQUE, N.M. and SEOUL, South Korea, April 25, 2023 /PRNewswire/ -- Indica Labs, an industry leader in...
HAMBURG, Germany--(BUSINESS WIRE)--In a first of its kind comparative study, Mindpeak's CE-marked HER2 AI for breast cancer diagnosis was compared to three other commercial AIs (e.g. Visiopharm). Mindpeak's AI showed the highest accuracy of...
